Pharmaceutical compositions containing a compound of formula (I)

##STR00001##

wherein the radicals denote e.g.: R.sup.1 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.2 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.3 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.4 is OH; R.sup.5 is hydrogen,
and a pharmaceutically acceptable cyclodextrin derivative can be used for the preparation of ophthalmic formulations.

Pharmaceutical compositions containing a compound of formula (I)

##STR00001##

wherein the radicals denote e.g.: R.sup.1 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.2 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.3 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.4 is OH; R.sup.5 is hydrogen,
and a pharmaceutically acceptable cyclodextrin derivative can be used for the preparation of ophthalmic formulations.

Pharmaceutical compositions containing a compound of formula (I)

##STR00001##

wherein the radicals denote e.g.: R.sup.1 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.2 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.3 is hydrogen or C.sub.1-C.sub.8-alkyl; R.sup.4 is OH; R.sup.5 is hydrogen,
and a pharmaceutically acceptable cyclodextrin derivative can be used for the preparation of ophthalmic formulations.

Disclosed herein are methods of treating viral infections by administration of ethyl mercury or thiol derivative thereof in an amount effective to treat the viral infection.

Disclosed herein are methods of treating viral infections by administration of ethyl mercury or thiol derivative thereof in an amount effective to treat the viral infection.

The present invention relates to a combination comprising at least one compound selected from the group consisting of an -adrenergic antagonist, an anthelmintic agent, an antifungal agent, an antimalarial agent, an antineoplastic agent, an antipsychotic agent, an antioxidant, a vasodilator, a vitamin, or a pharmaceutically acceptable derivative thereof; and an antimicrobial compound.

The present invention relates to a combination comprising at least one compound selected from the group consisting of an -adrenergic antagonist, an anthelmintic agent, an antifungal agent, an antimalarial agent, an antineoplastic agent, an antipsychotic agent, an antioxidant, a vasodilator, a vitamin, or a pharmaceutically acceptable derivative thereof; and an antimicrobial compound.

The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.

The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.

The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.